Peptide Therapy for Hair Growth: What the Evidence Says About GHK-Cu and PTD-DBM
Clinical Summary & Executive TakeawayFast Read
Evidence Grade
Peer-Reviewed Clinical Evidence
Target Pathway
Mechanistic Follicle Biology
Safety & Tolerance Note:
Standard safety profile; consult a board-certified dermatologist.
Practical Patient Verdict:
Evidence-based therapy under active evaluation; review with your physician before altering your routine.
As researchers continue to explore the potential of peptide therapy for hair loss, two compounds have emerged as particularly promising: GHK-Cu and PTD-DBM. This analysis'll examine the science behind these peptides, separating hype from reality, and explore what their development might mean for the future of hair loss treatment.
Clinical Trial Evidence & Research Figures
4 Figures AvailableSign in to like, save, or comment.
References & Clinical Data
- Platelet-rich plasma for androgenetic alopecia: a review , Giordano S, et al. (International Journal of Molecular Sciences, 2023)
- Wnt-dependent de novo hair follicle regeneration in adult mouse skin , Ito M, et al. (Nature, 2007)
- Hair follicle stem cells and their niche , Rompolas P, Greco V (Journal of Investigative Dermatology, 2014)
- Prostaglandin D2 inhibits hair growth and is elevated in bald scalp , Garza LA, et al. (Science Translational Medicine, 2012)



